Drug Shortage Report for PMS-SOLIFENACIN
Report ID | 202582 |
Drug Identification Number | 02417723 |
Brand name | PMS-SOLIFENACIN |
Common or Proper name | SOLIFENACIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 & 100 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-08-21 |
Estimated end date | 2025-04-22 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-01-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2025-01-07 | French | Compare |
v12 | 2025-01-07 | English | Compare |
v11 | 2024-09-12 | French | Compare |
v10 | 2024-09-12 | English | Compare |
v9 | 2024-09-12 | French | Compare |
v8 | 2024-09-12 | English | Compare |
v7 | 2024-04-29 | French | Compare |
v6 | 2024-04-29 | English | Compare |
v5 | 2023-10-16 | French | Compare |
v4 | 2023-10-16 | English | Compare |
v3 | 2023-08-22 | English | Compare |
v2 | 2023-08-21 | French | Compare |
v1 | 2023-08-21 | English | Compare |
Showing 1 to 13 of 13